Skip to main content

INCA036873

INCA036873 is an investigational CD70×CD3 bispecific antibody with high affinity for CD70.1a

Recruiting & Ongoing Clinical Studies

Condition
Study Title
Phase
Resources & Links
Renal cell carcinoma Lymphoma
An Open-Label, Multicenter Study of INCA036873 in Patients with Advanced Solid Tumors and Hematologic Malignancies
1

Cluster of Differentiation 70 (CD70)

CD70 is a member of the TNF superfamily.1,2

  • CD27, a TNF receptor family member, is its sole receptor.1,2

Under normal physiological conditions, CD70-CD27 signaling promotes T-cell activation, survival, and differentiation.1

Although CD70 expression is limited in healthy tissues, aberrant and sustained CD70 upregulation is observed in various hematologic and solid malignancies, including renal cell carcinoma and B-cell and T-cell lymphomas.1,2

References: 1. Data on file. Incyte Corporation. 2. Wu R, et al. Front Oncol. 2025;15:1609840.

Top